Share Your Research, Maximize Your Social Impacts
Main Menu
Searching By
PARTNERS
Clinical Compliance 2011 - What are the Scientific Basis of Clinical Research and the hall mark of a good study protocol? - Clinical webinar By ComplianceOnline
Date2011-01-07
Deadline2011-01-07
VenuePalo Alto, USA - United States 
KeywordsClinical Webinar ,conference,event.
Topics/Call fo Papers
Why Should You Attend:
The basis for determining that a drug or device is “Safe and effective” is a series of scientifically sound, appropriately blinded, statistically relevant, and ethically performed process and it controlled by the Investigators.
This Webinar goes over the scientific standards of the drug development process. Starting with the drug discovery process, the role of the dose response relationship, the role of the IND process is discussed. You will learn the regulations to follow in Phase I and the 6 major questions that must be answered in this Phase.
The determination of the first dose in humans is another critical point in the process. Learn the questions each Phase in the development process must answer and how that is managed.. In the end, it is the Safety or risk and the efficacy or benefit ratio, which must be favorable for the process to continue.
The basis for determining that a drug or device is “Safe and effective” is a series of scientifically sound, appropriately blinded, statistically relevant, and ethically performed process and it controlled by the Investigators.
This Webinar goes over the scientific standards of the drug development process. Starting with the drug discovery process, the role of the dose response relationship, the role of the IND process is discussed. You will learn the regulations to follow in Phase I and the 6 major questions that must be answered in this Phase.
The determination of the first dose in humans is another critical point in the process. Learn the questions each Phase in the development process must answer and how that is managed.. In the end, it is the Safety or risk and the efficacy or benefit ratio, which must be favorable for the process to continue.
Other CFPs
- How to Set up Data Monitoring Committees (DMCs / DSMBs) and what is effect on the Drug Development Process - Clinical webinar By ComplianceOnline
- How to investigate environmental monitoring excursion limits - Clinical webinar By ComplianceOnline
- Have a good plan for recruiting study subjects to eliminate the risk of failure - Clinical webinar By ComplianceOnline
- Introduction to Letters of Credit - Trade And Logistics webinar By ComplianceOnline
- The Employee Misconduct Boot Camp: the Psychology and Law of Managing Difficult Behavior - HR webinar By ComplianceOnline
Last modified: 2010-12-23 19:34:35